M. Vergouwen, M. Vermeulen, J. Van-gijn, G. Rinkel, E. Wijdicks et al., Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group, Stroke, vol.41, issue.10, pp.2391-2396, 2010.
DOI : 10.1161/STROKEAHA.110.589275

R. Jabbarli, R. M. Shah, M. Roelz, R. Niesen, W. Kaier et al., Early Vasospasm after Aneurysmal Subarachnoid Hemorrhage Predicts the Occurrence and Severity of Symptomatic Vasospasm and Delayed Cerebral Ischemia. Cerebrovasc Dis Basel Switz, Feb, vol.341, pp.5-6265, 2016.

R. Macdonald, Does Prevention of Vasospasm in Subarachnoid Hemorrhage Improve Clinical Outcome? Yes. Stroke, Jun, vol.144, issue.6, pp.31-34, 2013.

I. Siasios, E. Kapsalaki, and K. Fountas, Cerebral Vasospasm Pharmacological Treatment: An Update, Neurology Research International, vol.70, issue.3, pp.1-20, 2013.
DOI : 10.1186/1745-6215-13-102

C. Washington, C. Derdeyn, R. Dhar, E. Arias, M. Chicoine et al., A Phase I proof-of-concept and safety trial of sildenafil to treat cerebral vasospasm following subarachnoid hemorrhage, Journal of Neurosurgery, vol.124, issue.2, pp.318-345, 2016.
DOI : 10.3171/2015.2.JNS142752

N. Etminan, M. Vergouwen, D. Ilodigwe, and R. Macdonald, Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis, Journal of Cerebral Blood Flow & Metabolism, vol.2, issue.3, pp.1443-51, 2011.
DOI : 10.1161/STROKEAHA.107.484360

G. Allen, H. Ahn, T. Preziosi, R. Battye, S. Boone et al., Cerebral Arterial Spasm ??? A Controlled Trial of Nimodipine in Patients with Subarachnoid Hemorrhage, New England Journal of Medicine, vol.308, issue.11, pp.619-643, 1983.
DOI : 10.1056/NEJM198303173081103

D. Tettenborn and J. Dycka, Prevention and treatment of delayed ischemic dysfunction in patients with aneurysmal subarachnoid hemorrhage, Stroke J Cereb Circ, 1990.

D. Tettenborn, J. Dycka, E. Volberg, and P. Düdden, Blood pressure and heart rate during treatment with nimodipine in patients with subarachnoid hemorrhage. Neurochirurgia (Stuttg), pp.84-90, 1985.

K. Petruk, M. West, G. Mohr, B. Weir, B. Benoit et al., Nimodipine treatment in poor-grade aneurysm patients, Journal of Neurosurgery, vol.68, issue.4, pp.505-522, 1988.
DOI : 10.3171/jns.1988.68.4.0505

F. Barker and C. Ogilvy, Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis, Journal of Neurosurgery, vol.84, issue.3, pp.405-419, 1996.
DOI : 10.3171/jns.1996.84.3.0405

R. Macdonald, M. Diringer, and G. Citerio, Understanding the disease: aneurysmal subarachnoid hemorrhage. Intensive Care Med, pp.1940-1943, 2014.

M. Kimball, G. Velat, and B. Hoh, Critical Care Guidelines on the Endovascular Management of Cerebral Vasospasm. Neurocrit Care, The Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage, pp.336-377, 2011.

G. Dabus and R. Nogueira, Current Options for the Management of Aneurysmal Subarachnoid Hemorrhage-Induced Cerebral Vasospasm: A Comprehensive Review of the Literature, Interventional Neurology, vol.2, issue.1, pp.30-51, 2013.
DOI : 10.1159/000354755

A. Fraticelli, B. Cholley, M. Losser, S. Maurice, J. Payen et al., Milrinone for the Treatment of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage. Stroke, pp.893-901, 2008.

J. Shankar, M. Santos, L. Deus-silva, and C. Lum, Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage, Neuroradiology, vol.51, issue.2, pp.123-131, 2011.
DOI : 10.1007/s00234-010-0720-7

J. Durrant and H. Hinson, Rescue Therapy for Refractory Vasospasm after Subarachnoid Hemorrhage Available from, Curr Neurol Neurosci Rep, vol.15, issue.2, pp.11910-11924, 2015.

M. Lannes, J. Teitelbaum, M. Del-pilar-cortés, M. Cardoso, and A. M. , Milrinone and Homeostasis to Treat Cerebral Vasospasm Associated with Subarachnoid Hemorrhage: The Montreal Neurological Hospital Protocol, Neurocritical Care, vol.11, issue.3, pp.354-62, 2012.
DOI : 10.1007/s12028-012-9701-5

M. Diringer, T. Bleck, C. Hemphill, J. Menon, D. Shutter et al., Critical Care Management of Patients Following Aneurysmal Subarachnoid Hemorrhage: Recommendations from the Neurocritical Care Society???s Multidisciplinary Consensus Conference, Neurocritical Care, vol.34, issue.2, pp.211-251, 2011.
DOI : 10.1007/s12028-011-9605-9

D. Goldsher, R. Shreiber, V. Shik, Y. Tavor, and J. Soustiel, Role of multisection CT angiography in the evaluation of vertebrobasilar vasospasm in patients with subarachnoid hemorrhage, AJNR Am J Neuroradiol, vol.25, issue.9, pp.1493-1501, 2004.

J. Baron, Perfusion Thresholds in Human Cerebral Ischemia: Historical Perspective and Therapeutic Implications, Cerebrovascular Diseases, vol.11, issue.1, pp.2-8, 2001.
DOI : 10.1159/000049119

C. Fisher, J. Kistler, and J. Davis, Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning, Neurosurgery, 1980.

S. Fang, W. Brinjikji, M. Murad, D. Kallmes, H. Cloft et al., Endovascular Treatment of Anterior Communicating Artery Aneurysms: A Systematic Review and Meta-Analysis, American Journal of Neuroradiology, vol.35, issue.5, pp.943-950, 2014.
DOI : 10.3174/ajnr.A3802

S. Hallout, Surgical Treatment of Middle Cerebral Artery Aneurysms Without Using Indocyanine Green Videoangiography Assistance: Retrospective Monocentric Study of 263 Clipped Aneurysms, World Neurosurgery, vol.84, issue.4, pp.972-979, 2015.
DOI : 10.1016/j.wneu.2015.05.069

N. Sadamasa, K. Yoshida, O. Narumi, M. Chin, and S. Yamagata, Milrinone via lumbar subarachnoid catheter for vasospasm after aneurysmal subarachnoid hemorrhage. Neurocrit Care, pp.470-475, 2014.

P. Jun, N. Ko, J. English, C. Dowd, V. Halbach et al., Endovascular Treatment of Medically Refractory Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage, American Journal of Neuroradiology, vol.31, issue.10, pp.1911-1917, 2010.
DOI : 10.3174/ajnr.A2183

J. Lee, G. Kim, H. Kwon, B. Kwon, E. Bae et al., Safety and Efficacy of the Off-Label Use of Milrinone in Pediatric Patients with Heart Diseases, Korean Circulation Journal, vol.44, issue.5, p.320, 2014.
DOI : 10.4070/kcj.2014.44.5.320

J. Anderson, D. Baim, S. Fein, R. Goldstein, T. Lejemtel et al., Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: A multicenter study, Journal of the American College of Cardiology, vol.9, issue.4, pp.711-733, 1987.
DOI : 10.1016/S0735-1097(87)80223-1

K. Krajewski, S. Dombek, T. Martens, J. Köppen, M. Westphal et al., Neuropsychological assessments in patients with aneurysmal subarachnoid hemorrhage, perimesencephalic SAH, and incidental aneurysms, Neurosurgical Review, vol.154, issue.1, pp.55-62, 2014.
DOI : 10.1007/s10143-013-0489-3

A. Molyneux, R. Kerr, L. Yu, M. Clarke, M. Sneade et al., International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion, The Lancet, vol.366, issue.9488, pp.809-826, 2005.
DOI : 10.1016/S0140-6736(05)67214-5

T. Al-khindi, R. Macdonald, and T. Schweizer, Cognitive and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage, Stroke, vol.41, issue.8, pp.519-555, 2010.
DOI : 10.1161/STROKEAHA.110.581975

P. Gomis, J. Graftieaux, R. Sercombe, D. Hettler, B. Scherpereel et al., Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage, Journal of Neurosurgery, vol.112, issue.3, pp.681-689, 2010.
DOI : 10.3171/2009.4.JNS081377